FDA accepts Sarepta's applications to convert two DMD drugs to full approval
Go back to FDA accepts Sarepta's applications to convert two DMD drugs to full approval| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 15.87 +0.05 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.82 | 52 Week High | $63.73 | |||
| Open | $15.57 | 52 Week Low | $8.00 | |||
| Day High | $16.02 | P/E | N/A | |||
| Day Low | $15.43 | EPS | $-5.69 | |||
| Volume | 664,092 | |||||
